These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 15467018
1. Reducing the risk of coronary heart disease via lipid reduction. Spratt KA. J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S9-13. PubMed ID: 15467018 [Abstract] [Full Text] [Related]
2. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J. Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317 [Abstract] [Full Text] [Related]
3. Cholesterol: precursor to many lipid disorders. Jones PH. Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815 [Abstract] [Full Text] [Related]
4. Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents. Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH. Am J Cardiol; 2006 Nov 01; 98(9):1231-3. PubMed ID: 17056335 [Abstract] [Full Text] [Related]
5. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed? Sarawate CA, Cziraky MJ, Stanek EJ, Willey VJ, Corbelli JC, Charland SL. Clin Ther; 2007 Jan 01; 29(1):196-209. PubMed ID: 17379061 [Abstract] [Full Text] [Related]
6. Preventive strategies for reducing coronary heart disease-related morbidity and mortality in patients with multiple risk factors. Brown WV. J Am Osteopath Assoc; 2001 Sep 01; 101(9 Suppl):S6-11. PubMed ID: 11575043 [Abstract] [Full Text] [Related]
7. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia. Sorensen SV, Frick KD, Wade A, Simko R, Burge R. Clin Ther; 2009 Apr 01; 31(4):862-79. PubMed ID: 19446159 [Abstract] [Full Text] [Related]
8. Utility of currently available modes of therapy in reaching lipid goals. Spratt KA, Denke MA. J Am Osteopath Assoc; 2004 Sep 01; 104(9 Suppl 7):S14-6. PubMed ID: 15467019 [Abstract] [Full Text] [Related]
9. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Stone NJ, Bilek S, Rosenbaum S. Am J Cardiol; 2005 Aug 22; 96(4A):53E-59E. PubMed ID: 16098845 [Abstract] [Full Text] [Related]
10. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS, Mikhailidis DP. Curr Med Res Opin; 2006 Mar 22; 22(3):511-28. PubMed ID: 16574035 [Abstract] [Full Text] [Related]
17. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin. Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M, DISCOVERY PENTA investigators. Curr Med Res Opin; 2005 Aug 22; 21(8):1307-15. PubMed ID: 16083541 [Abstract] [Full Text] [Related]
18. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events. Balbisi EA. Med Sci Monit; 2006 Feb 22; 12(2):RA34-9. PubMed ID: 16449961 [Abstract] [Full Text] [Related]
19. Pathophysiology of coronary heart disease: a brief review. Chilton RJ. J Am Osteopath Assoc; 2004 Sep 22; 104(9 Suppl 7):S5-8. PubMed ID: 15467017 [Abstract] [Full Text] [Related]